أوروبا · وكالات وأخبار لحظية · Reuters US Markets

Swiss drug developer Windward Bio files for US IPO

نشره Reuters US Markets · المملكة المتحدة منذ 10 س

Windward Bio filed for a US initial public offering on Friday, becoming the latest drug developer seeking to capitalize on renewed ‌investor interest in biotech listings.

اقرأ المقال كاملًا على Reuters US Markets سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.reuters.com)

يستحق القراءة أيضًا

TASS

Saudi Arabia not to host Intervision this year — TASS source

Anadolu Agency

New York stock market closes week lower

Reuters Technology

AI 'hallucinations' in court filings show signs of slowdown, but judges still sound alarms

Fastmarkets

Fastmarkets proposes calculated FOB South America lithium carbonate, hydroxide prices

Reuters Business

What is going on with SpaceX's Starlink and Starshield in Ukraine?

Reuters